Table 5 Median cost to patients of a pediatric dose (unit-dose packages specifically intended to treat a 2 year/10 kg child) formulation of quality-assured artemisinin combination therapies in remote areas and non-remote areas at the endline in Ghana and Kenya, in US dollars, 2011–2012

All QAACTs

 Ghana, total

0.38 (0.31–0.63)

0.63 (0.63–0.94)

0.0102

  Public health facility

0.28 (0.24–0.47)

0.24 (0.24–0.47)

0.7121

  Private not-for-profit health facility^a

–

0.59 (0.24–0.94)

–

  Private for-profit outlet

0.63 (0.63–0.94)

0.63 (0.63–0.94)

0.7731

  Community health worker^a

0.31 (0.31–0.38)

–

–

 Kenya, Total

0.00 (0.00–0.46)

0.35 (0.00–0.46)

<0.0001

  Public health facility

0.00 (0.00–0.00)

0.00 (0.00–0.00)

–

  Private not-for-profit health facility^a

0.00 (0.00–0.23)

0.00 (0.00–0.46)

0.8642

  Private for-profit outlet

0.46 (0.35–0.58)

0.46 (0.35–0.46)

0.2123

  Community health worker^a

0.58

–

–

QAACTs with AMFm logo

 Ghana, total

0.63 (0.42–0.84)

0.63 (0.63–0.94)

0.4033

  Public health facility

0.24 (0.24–0.47)

0.24 (0.24–0.43)

0.9041

  Private not-for-profit health facility^a

–

0.59 (0.24–0.94)

–

  Private for-profit outlet

0.63 (0.63–0.94)

0.63 (0.63–0.94)

0.8613

  Community health worker^a

–

–

–

 Kenya, total

0.00 (0.00–0.46)

0.35 (0.23–0.46)

<0.0001

  Public health facility

0.00 (0.00–0.00)

0.00 (0.00–0.00)

0.4845

  Private not-for-profit health facility^a

0.00 (0.00–0.00)

0.00 (0.00–0.58)

0.7213

  Private for-profit outlet

0.46 (0.35–0.58)

0.46 (0.35–0.46)

0.2731

  Community health worker^a

0.58

–

–